[
    "{\"step_by_step_thinking\": \"Tisagenlecleucel is a type of CAR-T cell therapy. It is a treatment that modifies the patient's own T cells to fight cancer. It has been approved by the FDA for the treatment of certain types of B-cell lymphoma, including diffuse large B-cell lymphoma (DLBCL), high grade B-cell lymphoma, and DLBCL arising from follicular lymphoma. Therefore, it is effective for B-Cell Lymphoma.\", \"answer_choice\": \"A\"}"
]